In every corner of the FDA, and at sister health agencies like the CDC, support staff, specialists, and scientists were hit ...

The U.S. Department of Health and Human Services (HHS) embarks on a significant restructuring, potentially leading to the ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

Layoffs at the Food and Drug Administration are expected to reduce the FDA's workforce by 20%. Susan Mayne, former director ...

The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency ...

The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs ...

In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

The mass layoffs of federal workers under Health Secretary Robert F. Kennedy Jr. have impaired data-gathering on critical ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.

Mass layoffs at the U.S. Department of Health and Human Services (HHS), including the Food and Drug Administration (FDA), will impact the medical device regulatory process, says Ben Wolf, partner in ...